What is the appropriate duration of antibiotic therapy for group B Streptococcus bacteremia?

Duration of Antibiotic Therapy for Group B Streptococcus Bacteremia

For uncomplicated Group B Streptococcus (GBS) bacteremia, treat with 4 to 6 weeks of intravenous beta-lactam therapy, with gentamicin added for at least the first 2 weeks. 1

Treatment Duration Based on Clinical Context

Uncomplicated Bacteremia (Native Valve)

• 4 to 6 weeks of antimicrobial therapy is the standard recommendation for Group B streptococcal bacteremia 1
• The addition of gentamicin to penicillin or ceftriaxone for at least the first 2 weeks of the 4- to 6-week course may be considered, as Group B streptococci are slightly more resistant to penicillin than Group A streptococci 1

Prosthetic Valve Endocarditis

• 6 weeks of therapy is reasonable for prosthetic valve endocarditis caused by streptococci 1
• This longer duration accounts for the increased difficulty in eradicating infection from prosthetic material 1

Antibiotic Selection

First-Line Regimens

• Penicillin G 12–18 million units/day IV in 4–6 divided doses 2
• Ceftriaxone 2 g/day IV in 1 dose 1, 2
• Ampicillin 2 g IV every 4 hours 1

Combination Therapy

• Add gentamicin 3 mg/kg/day IV in 1 dose for the first 2 weeks 1, 2
• This combination provides synergistic bactericidal activity against Group B streptococci 1

Beta-Lactam Allergy

• Vancomycin 30 mg/kg per 24 hours IV in 2 equally divided doses is reasonable only for patients unable to tolerate penicillin or ceftriaxone 1

Key Clinical Considerations

Source Control and Complications

• Group B streptococci can produce abscesses and may require adjunctive surgical intervention 2
• Early cardiac surgical intervention has improved overall survival rates in beta-hemolytic streptococcal endocarditis 1
• Always exclude endocarditis in patients with GBS bacteremia, as this fundamentally changes treatment duration 1

Shorter Duration Evidence

While recent research suggests that 5-10 days of therapy may be non-inferior to 11-15 days for uncomplicated streptococcal bacteremia in general 3, these studies included mixed streptococcal species and did not specifically focus on Group B streptococci. The guideline-based recommendation of 4-6 weeks remains the standard for GBS bacteremia, particularly given that Group B streptococci are more resistant to penicillin than other beta-hemolytic streptococci and have a propensity for abscess formation 1, 2, 1.

Oral Step-Down Therapy

• Oral step-down therapy after initial IV treatment has been studied in streptococcal bacteremia and may be appropriate for selected patients who achieve clinical stability 4, 5
• However, this approach should be reserved for uncomplicated cases without endocarditis, with documented clinical improvement and adequate source control 4, 5

Common Pitfalls to Avoid

• Do not use short-course therapy (7-14 days) for GBS bacteremia without careful consideration, as guidelines specifically recommend 4-6 weeks for beta-hemolytic streptococci 1
• Do not omit gentamicin in the first 2 weeks, as synergy is important given the relative penicillin resistance of Group B streptococci 1
• Always rule out endocarditis with appropriate imaging (echocardiography), as this mandates the full 6-week course 1
• Consult infectious diseases given the relative infrequency and complexity of beta-hemolytic streptococcal bacteremia 1